Business Standard

Sunday, January 19, 2025 | 02:53 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Glenmark Life IPO subscribed 2.8x on Day-1 on strong retail interest

The wholly-owned subsidiary of Glenmark Pharma is issuing Rs 1,060 cr fresh equity and offer for sale of 6.3 million shares worth Rs 453.6 crore

Glenmark Pharmaceuticals
Premium

Glenmark Pharmaceuticals

Sundar Sethuraman Mumbai
The initial public offer (IPO) of Glenmark Life Sciences was subscribed 2.8 times on Tuesday, the first day of the issue.

The wealthy investor portion was subscribed 88 per cent, and the retail portion was subscribed 5.3 times. On Monday, the company allotted shares worth Rs 454 crore to anchor investors.

The IPO closes on Thursday.

Glenmark Life Sciences, a developer and manufacturer of active pharmaceutical ingredients (APIs), has priced its IPO between Rs 695 and Rs 720 per equity share. At the upper end, the company will have a market cap of Rs 8,822 crore.

Glenmark Life, a wholly-owned

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in